A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib
Keywords: β-catenin; Melanoma; BRAF; Stat3; Resistance; Vemurafenib